Cambridge, MA, United States of America

Ying Mei

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
3 patents (USPTO):

Title: The Innovative Mind of Ying Mei: Pioneering Advances in Cell Separation Technology

Introduction

Ying Mei, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of biotechnology through his innovative work on cell separation technologies. With a total of three patents to his name, Ying Mei’s inventions are paving the way for advancements in medical and research applications.

Latest Patents

Among Ying Mei's latest patents is a groundbreaking system for cell separation which is based on the concept of cell rolling on surfaces along the edges of regions coated with cell adhesion molecules. This invention describes a variety of designs for coated regions and edges that enhance the efficiency of cell separation. This technology has the potential to improve research methodologies and clinical practices in biotechnology and medicine.

Career Highlights

Ying Mei is affiliated with the Massachusetts Institute of Technology, a prestigious research institution known for its cutting-edge innovation and development. His work at this renowned institution allows him to collaborate with some of the brightest minds in the field, further advancing his research and impact in biotechnology.

Collaborations

Throughout his career, Ying Mei has worked closely with esteemed colleagues such as Rohit Nandkumar Karnik and Seungpyo Hong. Their collaborations have fueled the development of innovative solutions that address complex challenges in cell manipulation and separation, enhancing the capabilities of research and biotechnology applications.

Conclusion

Ying Mei's contributions to the world of cell separation technology exemplify the spirit of innovation and the persistent pursuit of scientific advancement. With his inventive mindset and collaborative approach, he continues to lead the charge in developing technologies that could transform the landscape of medical research and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…